SGS Advances Clinical Trial Data Management with Veeva Vault EDC

Global CRO to Use Veeva Vault CDMS for Simplified Trial Design and Better Data Quality

Barcelona, ​​Spain, June 7, 2022 /PRNewswire/ — Veeva systems (NYSE: VEEV) today announced that SGS Health Science, a leading contract research organization (CRO), has adopted Veeva Vault EDC to improve site data capture and quality for faster study cycle times during clinical trials. The app is part of CDMS Veeva Vault, providing SGS with better data oversight and greater flexibility in test design and execution. With Vault EDC, SGS can translate complex protocols into user-friendly casebook designs and make mid-course adjustments without downtime or migrations.

“SGS is continually evolving its approach to data management to solve the challenges our biotech and pharmaceutical customers face in clinical trials,” said Joris DeBondt, EDC Manager, SGS Health Science. “With user-friendly features that meet today’s complex study needs, Veeva Vault EDC will allow us to better monitor and manage trials by leveraging reliable, real-time data from our sites.”

SGS offers global clinical research services for Phase I to IV trials focused on early development and biometrics. The addition of Vault EDC builds on SGS’s success in streamlining and automating testing processes with Veeva Vault CTMS and Veeva Vault eTMF. Using connected applications on a single cloud platform will provide better trial monitoring, real-time data and document management, and faster trial processes, such as payments to research sites. Going forward, SGS plans to leverage Veeva RTSM to optimize data quality and trial efficiency.

“We are proud to partner with SGS and support their commitment to advancing the speed and efficiency of clinical trials,” said Paul MacDonald, Senior Director, Strategy, Veeva Vault CDMS. “With the addition of Veeva Vault EDC, SGS will strengthen its oversight and data management across its vast network of research sites conducting clinical trials.”

Further information
To learn more about Veeva Vault EDC, visit:
Connect with Veeva on LinkedIn:
Follow @veeva_eu on Twitter:

About SGS
SGS provides high quality analytical testing and clinical research services to support drug discovery, registration, development and manufacturing. We leverage our network of laboratories, production and clinical trial facilities in North America, Europeand Asia Pacificto support you every step of the way to deliver first-class, fully compliant biopharmaceutical and pharmaceutical drugs and medical devices.

Further information
To learn more about SGS CR, visit:
Connect with SGS on LinkedIn:

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a public benefit company, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit

Veeva forward-looking statements
This release contains forward-looking statements regarding Veeva products and services and expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this press release and we undertake no obligation to update these statements. There are numerous risks that could adversely impact our results, including the risks and uncertainties disclosed in our Form 10-Q filing for the period ended April 30, 2022that you can find here (you will find a summary of the risks that could impact our business on pages 37 and 38) and in our subsequent filings with the SEC, which you can access at


SOURCE Veeva Systems